top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjcvp

Vice versa, patients presenting with acute coronary syndromes (ACS) develop AF in 621% of cases, hence, through the presence of vascular disease, these patients automatically require anticoagulation ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Miklos Rohla, Thomas W. Weiss, Johann Wojta, Alexander Niessner, Kurt Huber

Date : 01/07/2015 Item size : 293945 bytes
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes
Ehjcvp

The EMPA-REG outcome trial showed improved survival and less hospitalization for HF: it is changing concepts and practice.1 The new era of outcome trials follows the acute awareness of the need to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Basil S. Lewis

Date : 01/10/2016 Item size : 203582 bytes
Ehjcvp

In this issue of the journal, Dr Vries and co-workers report data from a study that aimed to explore the level of agreement between windows for different platelet function tests (PFTs) used to ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Stefan Agewall

Date : 01/01/2017 Item size : 132260 bytes